Effects of acute acamprosate and homotaurine on ethanol intake and ethanol-stimulated mesolimbic dopamine release

M. Foster Olive, Michelle A. Nannini, Christine J. Ou, Heather N. Koenig, Clyde W. Hodge

Research output: Contribution to journalArticle

67 Scopus citations

Abstract

The purpose of the present study was to determine the acute effects of the anticraving compound acamprosate (calcium acetylhomotaurinate) and the closely related compound homotaurine on ethanol intake and ethanol-stimulated dopamine release in the nucleus accumbens. Male rats were treated with acamprosate (200 or 400 mg/kg intraperitoneally, i.p.) or homotaurine (10, 50, or 100 mg/kg i.p.) 15 min prior to access to 10% ethanol and water for 1 h in a two-bottle choice restricted access paradigm. A separate group of rats was implanted with microdialysis probes in the nucleus accumbens and given an acute injection of ethanol (1.5 g/kg i.p.) that was preceded by saline, acamprosate, or homotaurine. Acamprosate and homotaurine dose-dependently reduced ethanol intake and preference. These compounds also delayed or suppressed ethanol-stimulated increases in nucleus accumbens dopamine release, suggesting that acamprosate and homotaurine may reduce ethanol intake by interfering with the ability of ethanol to activate the mesolimbic dopamine reward system.

Original languageEnglish (US)
Pages (from-to)55-61
Number of pages7
JournalEuropean Journal of Pharmacology
Volume437
Issue number1-2
DOIs
StatePublished - Feb 15 2002
Externally publishedYes

Keywords

  • Acamprosate
  • Dopamine
  • Ethanol
  • Homotaurine
  • Microdialysis
  • Nucleus accumbens

ASJC Scopus subject areas

  • Pharmacology

Fingerprint Dive into the research topics of 'Effects of acute acamprosate and homotaurine on ethanol intake and ethanol-stimulated mesolimbic dopamine release'. Together they form a unique fingerprint.

  • Cite this